Arsenic and noncirrhotic portal hypertension.
D000328:Adult; D001151:Arsenic / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D001984:Bronchial Neoplasms / Q000139:chemically induced; D002277:Carcinoma / Q000139:chemically induced; D006801:Humans; D006975:Hypertension, Portal / Q000139:chemically induced* / Q000473:pathology; D007642:Keratosis / Q000139:chemically induced; D007822:Laryngeal Neoplasms / Q000139:chemically induced; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008875:Middle Aged; D010859:Pigmentation Disorders / Q000139:chemically induced; D011169:Portal Vein / Q000473:pathology / Q000502:physiology; D011565:Psoriasis / Q000188:drug therapy; D012878:Skin Neoplasms / Q000139:chemically induced; D013162:Splenic Vein / Q000502:physiology; D014690:Venous Pressure
D001151:Arsenic